Animal Health Surgery Drug Market, Global Outlook and Forecast 2024-2030
The global Animal Health Surgery Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Animal health surgery drugs are defined as drugs administered to animals most preferably before a surgery, after the surgery, or during the surgical procedure, based on the type of surgery being performed on the animal
This report aims to provide a comprehensive presentation of the global market for Animal Health Surgery Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Health Surgery Drug. This report contains market size and forecasts of Animal Health Surgery Drug in global, including the following market information:
Global Animal Health Surgery Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Opioids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Animal Health Surgery Drug include Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated, Virbac S.A., Biogenesis Bago SA, Piramal Group, Zoetis, NEOGEN Corporation. and Vetoquinol S.A., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Animal Health Surgery Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Health Surgery Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Animal Health Surgery Drug Market Segment Percentages, by Type, 2023 (%)
- Opioids
- Antibiotics
- Anesthetics
- Others
Global Animal Health Surgery Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Animal Health Surgery Drug Market Segment Percentages, by Application, 2023 (%)
- Orthopedic Surgery
- Dental Surgery
- Sterilization Surgery
- Others
Global Animal Health Surgery Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Animal Health Surgery Drug Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Animal Health Surgery Drug revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Animal Health Surgery Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck Animal Health (Merck & Co., Inc.)
- Boehringer Ingelheim International GmbH.
- Elanco Animal Health Incorporated
- Virbac S.A.
- Biogenesis Bago SA
- Piramal Group
- Zoetis
- NEOGEN Corporation.
- Vetoquinol S.A.
- Ceva Sant Animale
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal Health Surgery Drug, market overview.
Chapter 2: Global Animal Health Surgery Drug market size in revenue.
Chapter 3: Detailed analysis of Animal Health Surgery Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Health Surgery Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
